JP2013512256A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013512256A5 JP2013512256A5 JP2012541206A JP2012541206A JP2013512256A5 JP 2013512256 A5 JP2013512256 A5 JP 2013512256A5 JP 2012541206 A JP2012541206 A JP 2012541206A JP 2012541206 A JP2012541206 A JP 2012541206A JP 2013512256 A5 JP2013512256 A5 JP 2013512256A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- peptides
- sequence
- construct
- lcrv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26414409P | 2009-11-24 | 2009-11-24 | |
| US61/264,144 | 2009-11-24 | ||
| PCT/US2010/058094 WO2011066454A1 (en) | 2009-11-24 | 2010-11-24 | Compositions, methods and uses for expression of enterobacterium-associated peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013512256A JP2013512256A (ja) | 2013-04-11 |
| JP2013512256A5 true JP2013512256A5 (https=) | 2014-01-16 |
Family
ID=44066925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012541206A Pending JP2013512256A (ja) | 2009-11-24 | 2010-11-24 | 腸内細菌関連ペプチドの発現に関する組成物、方法、および使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9028809B2 (https=) |
| EP (1) | EP2504029A4 (https=) |
| JP (1) | JP2013512256A (https=) |
| AU (1) | AU2010324731B2 (https=) |
| CA (1) | CA2781645A1 (https=) |
| WO (1) | WO2011066454A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10174100B1 (en) * | 2006-11-06 | 2019-01-08 | Microvax, Llc | Multivalent DNA composition for Yersinia pestis |
| EP3054006A1 (en) | 2015-02-09 | 2016-08-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography |
| CN107103128B (zh) * | 2017-04-19 | 2019-11-05 | 西北工业大学 | 基于多准则妥协解排序的多目标威胁评估方法 |
| JP7695607B2 (ja) * | 2021-06-18 | 2025-06-19 | トヨタ紡織株式会社 | シアノバクテリアの製造方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| US6764685B1 (en) | 2000-03-21 | 2004-07-20 | Medimmune Vaccines, Inc. | Recombinant parainfluenza virus expression systems and vaccines |
| US7875280B2 (en) * | 2004-12-02 | 2011-01-25 | The University Of Chicago | Methods and compositions involving LcrV proteins |
| CA2627302A1 (en) * | 2005-10-25 | 2007-05-03 | Novartis Vaccines And Diagnostics S.R.L. | Compositions comprising yersinia pestis antigens |
| US8268327B2 (en) * | 2007-04-27 | 2012-09-18 | Bavarian Nordic A/S | Immediate protection against pathogens via MVA |
| WO2009079564A2 (en) | 2007-12-17 | 2009-06-25 | Emory University | Immunogenic compositions and methods of use thereof |
| WO2010022225A1 (en) * | 2008-08-20 | 2010-02-25 | Ibc Pharmaceuticals, Inc. | Dock-and-lock (dnl) vaccines for cancer therapy |
| WO2010127115A1 (en) * | 2009-04-30 | 2010-11-04 | Centre Hospitalier Universitaire Vaudois Lausanne (Chuv) | Modified immunization vectors |
-
2010
- 2010-11-24 EP EP10833974.8A patent/EP2504029A4/en not_active Withdrawn
- 2010-11-24 CA CA2781645A patent/CA2781645A1/en not_active Abandoned
- 2010-11-24 WO PCT/US2010/058094 patent/WO2011066454A1/en not_active Ceased
- 2010-11-24 AU AU2010324731A patent/AU2010324731B2/en not_active Ceased
- 2010-11-24 JP JP2012541206A patent/JP2013512256A/ja active Pending
- 2010-11-24 US US13/511,652 patent/US9028809B2/en not_active Expired - Fee Related
-
2015
- 2015-04-06 US US14/679,944 patent/US20150343046A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102135818B1 (ko) | 강력한 ｔ-세포 및 항체 반응을 위한 ｐｒ13.5 프로모터 | |
| DK2558581T3 (en) | POX VIRUS EXPRESSION SYSTEM | |
| JP6743154B2 (ja) | Ｈｂｖを処置するための手段及び方法 | |
| Shi et al. | Immunoprotection against influenza virus H9N2 by the oral administration of recombinant Lactobacillus plantarumNC8 expressing hemagglutinin in BALB/c mice | |
| ES2898235T3 (es) | Secuencias de aminoácidos y de ácidos nucleicos de adenovirus de simio, vectores que las contienen, y sus usos | |
| US20230381297A1 (en) | Attenuated poxvirus vector based vaccine for protection against covid-19 | |
| CN101321781B (zh) | 一种核苷酸疫苗 | |
| US10059747B2 (en) | Crimean-congo haemorrhagic fever virus antigenic composition | |
| JP2020516264A5 (https=) | ||
| AU2022205166A1 (en) | Recombinant modified vaccinia virus Ankara (MVA) Foot and mouth disease virus (FMDV) vaccine | |
| CN103627718B (zh) | 表达ibv s1和n双抗原蛋白重组质粒及其构建方法和应用 | |
| WO2019115816A1 (en) | Hepatitis b immunisation regimen and compositions | |
| CN107454848A (zh) | 用于诱导针对丝状病毒感染的保护性免疫的方法和组合物 | |
| AU2022205163A1 (en) | Hepatitis B immunisation regimen and compositions | |
| JP2021507712A (ja) | エプスタインバールウイルス抗原構築物 | |
| JP2013512256A5 (https=) | ||
| ES3056141T3 (en) | Simian adenoviral vectors with two expression cassettes | |
| Zhang et al. | Construction of an oral vaccine for transmissible gastroenteritis virus based on the TGEV N gene expressed in an attenuated Salmonella typhimurium vector | |
| JP2020537526A (ja) | Ｒｓｖ抗原性タンパク質又はその断片をコードする２つの発現カセットを有するアデノウイルスベクター | |
| JP7240029B2 (ja) | フラビウイルスとリッサウイルスとのキメラワクチン | |
| Basirnejad et al. | Development of HCV therapeutic vaccines using Hp91 peptide and small heat shock protein 20 as an adjuvant | |
| WO2006002594A1 (en) | A recombinant canine adenovirus type-2 and the preparation method and usage thereof | |
| Rojas et al. | Adenovirus as tools in animal health | |
| WO2022084663A1 (en) | Compositions and methods for inducing an immune response | |
| CN103405767A (zh) | 传染性法氏囊病病毒样颗粒与单克隆抗体组合双功能疫苗 |